Nissan Medical Industries Ltd (NISA.TA)
ILA 1135.0
(-2.16%)
ILA 1135.0
(-2.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 733.91 Million ILS | 7.2% |
| 2022 | 684.64 Million ILS | 2.44% |
| 2021 | 668.37 Million ILS | -7.36% |
| 2020 | 721.48 Million ILS | 19.16% |
| 2019 | 605.46 Million ILS | -8.04% |
| 2018 | 658.38 Million ILS | 12.66% |
| 2017 | 584.38 Million ILS | 14.7% |
| 2016 | 509.47 Million ILS | -3.86% |
| 2015 | 529.95 Million ILS | 3.47% |
| 2014 | 512.2 Million ILS | 9.73% |
| 2013 | 466.78 Million ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 192.53 Million ILS | 0.1% |
| 2024 Q2 | 167.65 Million ILS | -12.92% |
| 2023 Q2 | 179.98 Million ILS | -2.77% |
| 2023 Q1 | 185.12 Million ILS | 2.66% |
| 2023 Q3 | 176.46 Million ILS | -1.95% |
| 2023 FY | 733.91 Million ILS | 7.2% |
| 2023 Q4 | 192.34 Million ILS | 9.0% |
| 2022 FY | 684.64 Million ILS | 2.44% |
| 2022 Q4 | 180.32 Million ILS | 8.51% |
| 2022 Q3 | 166.18 Million ILS | -0.4% |
| 2022 Q1 | 171.28 Million ILS | -0.77% |
| 2022 Q2 | 166.84 Million ILS | -2.59% |
| 2021 Q1 | 166.92 Million ILS | -7.08% |
| 2021 Q4 | 172.61 Million ILS | 17.02% |
| 2021 FY | 668.37 Million ILS | -7.36% |
| 2021 Q2 | 181.33 Million ILS | 8.63% |
| 2021 Q3 | 147.5 Million ILS | -18.65% |
| 2020 Q1 | 172.14 Million ILS | 13.21% |
| 2020 Q2 | 189.27 Million ILS | 9.95% |
| 2020 Q4 | 179.64 Million ILS | -0.43% |
| 2020 Q3 | 180.42 Million ILS | -4.68% |
| 2020 FY | 721.48 Million ILS | 19.16% |
| 2019 Q2 | 157.93 Million ILS | 11.23% |
| 2019 Q1 | 141.99 Million ILS | -21.37% |
| 2019 FY | 605.46 Million ILS | -8.04% |
| 2019 Q4 | 152.05 Million ILS | -0.93% |
| 2019 Q3 | 153.48 Million ILS | -2.82% |
| 2018 Q3 | 153.47 Million ILS | -10.09% |
| 2018 Q4 | 180.57 Million ILS | 17.66% |
| 2018 Q2 | 170.7 Million ILS | 11.11% |
| 2018 FY | 658.38 Million ILS | 12.66% |
| 2018 Q1 | 153.63 Million ILS | -0.01% |
| 2017 FY | 584.38 Million ILS | 14.7% |
| 2017 Q1 | 135.19 Million ILS | 3.7% |
| 2017 Q2 | 146.69 Million ILS | 8.51% |
| 2017 Q3 | 148.84 Million ILS | 1.46% |
| 2017 Q4 | 153.65 Million ILS | 3.24% |
| 2016 Q3 | 122.62 Million ILS | -6.94% |
| 2016 FY | 509.47 Million ILS | -3.86% |
| 2016 Q4 | 130.37 Million ILS | 6.32% |
| 2016 Q2 | 131.75 Million ILS | 5.64% |
| 2016 Q1 | 124.72 Million ILS | -8.4% |
| 2015 Q2 | 143.46 Million ILS | 12.44% |
| 2015 Q3 | 122.74 Million ILS | -14.45% |
| 2015 FY | 529.95 Million ILS | 3.47% |
| 2015 Q1 | 127.59 Million ILS | -6.38% |
| 2015 Q4 | 136.15 Million ILS | 10.93% |
| 2014 Q1 | 127.36 Million ILS | 10.08% |
| 2014 Q2 | 115.94 Million ILS | -8.96% |
| 2014 Q3 | 132.6 Million ILS | 14.37% |
| 2014 FY | 512.2 Million ILS | 9.73% |
| 2014 Q4 | 136.29 Million ILS | 2.78% |
| 2013 FY | 466.78 Million ILS | 0.0% |
| 2013 Q1 | 104.39 Million ILS | 0.0% |
| 2013 Q2 | 125.71 Million ILS | 20.42% |
| 2013 Q3 | 120.98 Million ILS | -3.76% |
| 2013 Q4 | 115.69 Million ILS | -4.37% |
| Name | Revenue | Revenue Difference |
|---|